# Barings BDC, Inc.: financial statements, quarterly

BBDC · NYSE · CIK 1379785 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbdc.md) · [Financials](/companies/bbdc/financials.md) · [Filings](/companies/bbdc/filings.md) · [Insiders](/companies/bbdc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbdc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [21.8](/filings/0001379785-23-000052.md) | [22.8 d](/filings/0001379785-24-000015.md) | [21.1](/filings/0001379785-24-000043.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [18.3 d](/filings/0001379785-24-000065.md) | [29.9 d](/filings/0001379785-26-000009.md) | [44.0](/filings/0001379785-25-000027.md) | [19.4 d](/filings/0001379785-25-000035.md) | [22.0 d](/filings/0001379785-25-000050.md) | [24.8 d](/filings/0001379785-26-000009.md) | [32.6](/filings/0001379785-26-000022.md) | [20.6 d](/filings/0001379785-26-000030.md) | [23.6 d](/filings/0001379785-25-000050.md) | [25.2 d](/filings/0001379785-26-000009.md) | [20.0](/filings/0001379785-26-000022.md) | [18.3 d](/filings/0001379785-26-000030.md) |
| Diluted EPS | $ per share | [0.31](/filings/0001379785-25-000010.md) | [0.31](/filings/0001379785-25-000010.md) | [0.28](/filings/0001379785-26-000009.md) | [0.40](/filings/0001379785-26-000009.md) | [0.29](/filings/0001379785-26-000009.md) | [0.28](/filings/0001379785-26-000009.md) | [0.25](/filings/0001379785-26-000022.md) | [0.28](/filings/0001379785-26-000030.md) | [0.32](/filings/0001379785-26-000009.md) | [0.27](/filings/0001379785-26-000009.md) | [0.25](/filings/0001379785-26-000022.md) | [0.28](/filings/0001379785-26-000030.md) |
| Basic EPS | $ per share | [0.31](/filings/0001379785-25-000010.md) | [0.31](/filings/0001379785-25-000010.md) | [0.28](/filings/0001379785-26-000009.md) | [0.40](/filings/0001379785-26-000009.md) | [0.29](/filings/0001379785-26-000009.md) | [0.28](/filings/0001379785-26-000009.md) | [0.25](/filings/0001379785-26-000022.md) | [0.28](/filings/0001379785-26-000030.md) | [0.32](/filings/0001379785-26-000009.md) | [0.27](/filings/0001379785-26-000009.md) | [0.25](/filings/0001379785-26-000022.md) | [0.28](/filings/0001379785-26-000030.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [2,742](/filings/0001379785-23-000052.md) | [2,677](/filings/0001379785-25-000010.md) | [2,699](/filings/0001379785-24-000043.md) | [2,604](/filings/0001379785-24-000055.md) | [2,605](/filings/0001379785-24-000065.md) | [2,696](/filings/0001379785-26-000009.md) | [2,791](/filings/0001379785-25-000027.md) | [2,793](/filings/0001379785-25-000035.md) | [2,822](/filings/0001379785-25-000050.md) | [2,636](/filings/0001379785-26-000030.md) | [2,600](/filings/0001379785-26-000022.md) | [2,584](/filings/0001379785-26-000030.md) |
| Total liabilities | $m | [1,543](/filings/0001379785-23-000052.md) | [1,481](/filings/0001379785-25-000010.md) | [1,487](/filings/0001379785-24-000043.md) | [1,402](/filings/0001379785-24-000055.md) | [1,411](/filings/0001379785-24-000065.md) | [1,505](/filings/0001379785-26-000009.md) | [1,603](/filings/0001379785-25-000027.md) | [1,617](/filings/0001379785-25-000035.md) | [1,655](/filings/0001379785-25-000050.md) | [1,476](/filings/0001379785-26-000030.md) | [1,447](/filings/0001379785-26-000022.md) | [1,438](/filings/0001379785-26-000030.md) |
| Long-term debt | $m | [720](/filings/0001379785-23-000052.md) | [721](/filings/0001379785-25-000010.md) | [1,011](/filings/0001379785-24-000043.md) | [1,009](/filings/0001379785-24-000055.md) | [1,021](/filings/0001379785-24-000065.md) | [1,012](/filings/0001379785-26-000009.md) | [1,018](/filings/0001379785-25-000027.md) | [1,021](/filings/0001379785-25-000035.md) | [1,266](/filings/0001379785-25-000050.md) | [1,203](/filings/0001379785-26-000030.md) | [1,122](/filings/0001379785-26-000022.md) | [1,117](/filings/0001379785-26-000030.md) |
| Shareholders' equity | $m | [1,198](/filings/0001379785-24-000065.md) | [1,197](/filings/0001379785-26-000009.md) | [1,212](/filings/0001379785-25-000035.md) | [1,202](/filings/0001379785-25-000050.md) | [1,194](/filings/0001379785-25-000050.md) | [1,190](/filings/0001379785-26-000030.md) | [1,189](/filings/0001379785-26-000030.md) | [1,176](/filings/0001379785-26-000030.md) | [1,167](/filings/0001379785-25-000050.md) | [1,161](/filings/0001379785-26-000030.md) | [1,153](/filings/0001379785-26-000030.md) | [1,146](/filings/0001379785-26-000030.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(34.9) d](/filings/0001379785-24-000065.md) | [139 d](/filings/0001379785-26-000009.md) | [4.9](/filings/0001379785-25-000027.md) | [138 d](/filings/0001379785-25-000035.md) | [24.1 d](/filings/0001379785-25-000050.md) | [(45.2) d](/filings/0001379785-26-000009.md) | [(7.8)](/filings/0001379785-26-000022.md) | [(52.7) d](/filings/0001379785-26-000030.md) | [16.5 d](/filings/0001379785-25-000050.md) | [205 d](/filings/0001379785-26-000009.md) | [68.0](/filings/0001379785-26-000022.md) | [15.8 d](/filings/0001379785-26-000030.md) |
| Dividends paid | $m | [27.7](/filings/0001379785-26-000009.md) | [27.7](/filings/0001379785-26-000009.md) | [27.6](/filings/0001379785-26-000009.md) | [27.5](/filings/0001379785-26-000009.md) | [27.5](/filings/0001379785-26-000009.md) | [27.4](/filings/0001379785-26-000009.md) | [32.7](/filings/0001379785-26-000022.md) | [32.6 d](/filings/0001379785-26-000030.md) | [32.6 d](/filings/0001379785-25-000050.md) | [27.3 d](/filings/0001379785-26-000009.md) | [27.2](/filings/0001379785-26-000022.md) | [27.2 d](/filings/0001379785-26-000030.md) |
| Share repurchases | $m | [0.0 d](/filings/0001379785-24-000065.md) | [3.9 d](/filings/0001379785-26-000009.md) | [1.1](/filings/0001379785-25-000027.md) | [1.9 d](/filings/0001379785-25-000035.md) | [2.0 d](/filings/0001379785-25-000050.md) | [1.5 d](/filings/0001379785-26-000009.md) | [1.5](/filings/0001379785-26-000022.md) | [0.9 d](/filings/0001379785-26-000030.md) | [0.0 d](/filings/0001379785-25-000050.md) | [4.0 d](/filings/0001379785-26-000009.md) | [0.0](/filings/0001379785-26-000022.md) | [0.0 d](/filings/0001379785-26-000030.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [109](/filings/0001379785-23-000052.md) | [108](/filings/0001379785-24-000043.md) | [107](/filings/0001379785-24-000055.md) | [107](/filings/0001379785-24-000065.md) | [106](/filings/0001379785-25-000027.md) | [106](/filings/0001379785-25-000035.md) | [106](/filings/0001379785-25-000050.md) | [105](/filings/0001379785-26-000022.md) | [105](/filings/0001379785-26-000030.md) | [105](/filings/0001379785-25-000050.md) | [105](/filings/0001379785-26-000022.md) | [105](/filings/0001379785-26-000030.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 104,706,884 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001379785-26-000030.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.